US 7812044
Anticancer agents
granted A61KA61K31/41A61K31/4178
Quick answer
US patent 7812044 (Anticancer agents) held by Takeda Pharmaceutical Company Limited expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/41, A61K31/4178, A61K31/4184, A61K31/4245